Status:
UNKNOWN
Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
Laboratoire parole et langage
Laboratoire Information Avignon université
Conditions:
Speech Intelligibility
Eligibility:
All Genders
18+ years
Brief Summary
The bridging of the gap between speech production and perception by the interlocutor would be made possible by the use of a more suitable and automatic task. An acoustic-phonetic decoding test (or DAP...
Detailed Description
Fifth cancer in terms of incidence in France, tumor pathologies of the upper aero-digestive tract, due to their location, impact the speech abilities of affected subjects. Speech therapy in paramedica...
Eligibility Criteria
Inclusion
- Patients aged at least 18 years old and benefiting from a social security scheme
- Native French-speaking patients
- Patients treated for cancer of the oral cavity or oropharynx (surgical and / or radiotherapy and / or chemotherapy treatment)
- Patients in clinical remission for at least 6 months (chronic nature and stability of the disorders)
- All tumor sizes according to the tumor (T), node (N), and metastasis (M) categories (TNM classification) (T1 to T4)
- Patients with a perceptible speech disorder in a conversational situation or not (to allow the determination of fine deficits)
- Patients who do not object to carrying out the research
Exclusion
- Patients with an associated pathology potentially responsible for speech or fluency disorders (joint, speech and language disorders of developmental, organic or functional origin, voice disorders of organic or functional origin, stammering , stammering, fluency disturbances, speech disturbances of neurological origin)
- Patients reporting an auditory complaint and not having a hearing aid
- Inability to provide the person with enlightened information and to ensure the subject's compliance because of impaired physical and / or psychological health,
- Patients participating in another research including an exclusion period still in progress.
Key Trial Info
Start Date :
October 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 22 2024
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04742998
Start Date
October 22 2021
End Date
October 22 2024
Last Update
July 24 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
AP- H Marseille - Hôpital de la Conception
Marseille, France
2
Institut universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
3
University Hospital Toulouse
Toulouse, France